EVALUATION OF TWO SUSTAINED-ACTION ORAL DECONGESTANTS: A CONTROLLED CLINICAL STUDY.
D018926:Anti-Allergic Agents; D035843:Biomedical Research; D006634:Histamine H1 Antagonists; D006801:Humans; D014663:Nasal Decongestants; D010033:Otitis Media; D010600:Pharmacology; D012130:Respiratory Hypersensitivity; D012141:Respiratory Tract Infections; D012220:Rhinitis; D006255:Rhinitis, Allergic, Seasonal; D012852:Sinusitis; D013566:Sympathomimetics; D014116:Toxicology; D014662:Vasoconstrictor Agents
D018926:Anti-Allergic Agents; D006634:Histamine H1 Antagonists; D014663:Nasal Decongestants; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents
ANTIHISTAMINICS; CLINICAL RESEARCH; HAY FEVER; OTITIS MEDIA; PHARMACOLOGY; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY TRACT INFECTIONS; RHINITIS; SINUSITIS; SYMPATHOMIMETICS; TOXICOLOGIC REPORT; VASOCONSTRICTOR AGENTS, NASAL